ERLONAT 100

Product Details:

Drug Type Specific Drug
Ingredients ERLOTINIB 150
Physical Form Tablets
Function Cancer Treatment
Recommended For LUNG CANCER,PANCREATIC CANCER
Dosage The recommended daily dose of TARCEVA for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs. Recommended Dose - Pancreatic Cancer The recommended daily dose of TARCEVA for pancreatic cancer is 100 mg taken once daily in combination with gemcitabine. Take TARCEVA on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs [see Clinical Studies]. Dose Modifications Adverse Reactions Pulmonary Interstitial Lung Disease (ILD) Discontinue TARCEVA During diagnostic evaluation for possible ILD Withhold TARCEVA* Hepatic Severe hepatic toxicity that does not improve significantly or resolve within three weeks Discontinue TARCEVA In patients with pre-existing hepatic impairment or biliary obstruction for doubling of bilirubin or tripling of transaminases values over baseline Withhold TARCEVA* and consider discontinuation In patients without pre-existing hepatic impairment for total bilirubin levels greater than 3 times the upper limit of normal or transaminases greater than 5 times the upper limit of normal Withhold ERLONAT and consider
Suitable For Teenagers Adults Aged Person
Share Your Product:

122.96-136.63 USD ($)/Bottle

Get a Price/Quote

Request To Call Back Send Inquiry

Price And Quantity

Minimum Order Quantity 2 Bottle
Price 122.96-136.63 USD ($)/Bottle

Product Specifications

Function Cancer Treatment
Physical Form Tablets
Drug Type Specific Drug
Storage Instructions ROOM TEMP. 10 -30 C
Suitable For Teenagers Adults Aged Person
Recommended For LUNG CANCER,PANCREATIC CANCER
Ingredients ERLOTINIB 150
Dosage The recommended daily dose of TARCEVA for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs. Recommended Dose - Pancreatic Cancer The recommended daily dose of TARCEVA for pancreatic cancer is 100 mg taken once daily in combination with gemcitabine. Take TARCEVA on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs [see Clinical Studies]. Dose Modifications Adverse Reactions Pulmonary Interstitial Lung Disease (ILD) Discontinue TARCEVA During diagnostic evaluation for possible ILD Withhold TARCEVA* Hepatic Severe hepatic toxicity that does not improve significantly or resolve within three weeks Discontinue TARCEVA In patients with pre-existing hepatic impairment or biliary obstruction for doubling of bilirubin or tripling of transaminases values over baseline Withhold TARCEVA* and consider discontinuation In patients without pre-existing hepatic impairment for total bilirubin levels greater than 3 times the upper limit of normal or transaminases greater than 5 times the upper limit of normal Withhold ERLONAT and consider

Trade Information

Payment Terms Cash in Advance (CID)
Supply Ability 20 Bottle Per Week
Delivery Time 2 Week
Packaging Details 1*30S
Main Export Market(s) Australia South America Middle East Africa Western Europe Asia Central America Eastern Europe North America
Main Domestic Market All India

Product Description

USES OF ERLONAT TABLET

Non-small cell lung cancer
Pancreatic cancer

BENEFITS OF ERLONAT TABLET

In Non-small cell lung cancer

Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Erlonat 150 Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

SIDE EFFECTS OF ERLONAT TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're worried about them

Common side effects of Erlonat

Abdominal pain
Bone painBreathlessness
Constipation
Cough
Diarrhea
Fatigue
Fever
Infection
Muscle pain
Nausea
Rash
Stomatitis (Inflammation of the mouth)
Vomiting
Weight loss

HOW TO USE ERLONAT TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlonat 150 Tablet is to be taken empty stomach.

HOW ERLONAT TABLET WORKS

Erlonat 150 Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.

Enter Buying Requirement Details

+ Add Attachment

Email Id

Mobile number

Please Wait...

Other Products in 'Pharmaceutical Tablets' category

Dabigratan 150 Storage Instructions : ROOM TEMP. 10 30 C Price : 88.7795.60 USD ($)/Box Drug Type : Generic Drugs Physical Form : Tablets Ingredients : DABIGATRAN ETEXILATE Minimum Order Quantity : 3 Recommended For : Dabigatran Etexilate is used for stroke prevention, heart attack, deep vein thrombosis and pulmonary embolism. It prevents the formation of blood clots in the legs, lungs, brain or heart. Quantity : 50 Boxes Function : Other Dosage : Mostly, Dabigatran Etexilate is suggested to be taken twice daily at the same time each day. The two doses should be taken at a gap of about 12 hours. If you miss a dose of Dabigatran Etexilate then take it as soon as possible up to 6 hours prior to the next scheduled dose. However, skip the missed dose if your next dose is less than 6 hours away. Never take two doses of Dabigatran Etexilate at the same time. Suitable For : Adults

Send Inquiry

RENODAPT 360 Storage Instructions : ROOM TEMP. 10 30 C Price : 16.3919.12 USD ($)/Pack Drug Type : Specific Drug Physical Form : Tablets Ingredients : MYCOPHENOLATE MOFETIL 360 Minimum Order Quantity : 10 Recommended For : PREVENTION OF ORGAN REJECTION IN TRANSPLANT PATIENT Quantity : 5 Boxes Function : Other Dosage : RENAL TRANSPLANTATION: 1 g orally or IV 2 times a day (2 gm per day); [in clinical trials, 1.5 g orally or IV 2 times a day (3 gm per day) was used effectively, however, the safety profile for 3 gm a day was lower] CARDIAC TRANSPLANTATION: 1.5 g orally or IV 2 times a day (3 gm per day) HEPATIC TRANSPLANTATION: 1.5 gm orally or 1 gm IV 2 times a day (3 gm per day orally or 2 gm per day IV) Suitable For : Suitable For All

Send Inquiry

BDRON 500MG Tablets Storage Instructions : ROOM TEMP. 10 30 C Price : 170.71177.53 USD ($)/Bottle Drug Type : Specific Drug Physical Form : Tablets Ingredients : ABIRATERONE Minimum Order Quantity : 3 Recommended For : Prostate Cancer Quantity : 10 Unit Function : Cancer Treatment Dosage : Prostate Cancer Metastatic castrationresistant prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic castrationresistant prostate cancer (CRPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Yonsa Indicated in combination with methylprednisolone for the treatment of patients with metastatic CRPC 500 mg (four 125mg tablets) PO qDay in combination with methylprednisolone 4 mg PO BID Suitable For : Aged Person

Send Inquiry

Tacrolimus Tablets Storage Instructions : ROOM TEMP. 10 30 C Price : 24.5927.32 USD ($)/Box Drug Type : Specific Drug Physical Form : Capsules Ingredients : TACROLIMUS Minimum Order Quantity : 10 Recommended For : PREVENTION OF ORGAN REJECTION IN TRANSPLANT PATIENT Function : Other Dosage : capsule, immediaterelease (Prograf, Hecoria) 0.5mg 1mg 5mg capsule, extendedrelease (Astagraf XL) 0.5mg 1mg 5mg tablet, extendedrelease (Envarsus XR) 0.75mg 1mg 4mg injectable solution (Prograf) 5mg/mL granules for oral suspension (Prograf) 0.2mg/packet 1mg/packet MORE... Heart Transplant Prophylaxis of organ rejection in patients receiving allogeneic transplants; use with azathioprine or mycophenolate mofetil (MMF) recommended IV: 0.01 mg/kg/day by continuous infusion initially PO (immediaterelease): 0.075 mg/kg/day divided q12hr initially Administer initial dose no sooner than 6 hr after transplantation Liver Transplant Prophylaxis of organ rejection in patients receiving allogeneic transplants IV: 0.030.05 mg/kg/day by continuous infusion initially PO (immediaterelease): 0.10.15 mg/kg/day divided q12hr initially Administer initial dose no sooner than 6 hr after transplantation Kidney Transplant Prograf Prophylaxis of organ rejection in patients receiving allogeneic kidney transplants; used concomitantly with azathioprine or MMF or interleukin (IL)2 receptor antagonist (eg, basiliximab or daclizumab) and corticosteroids PO (with azathioprine): 0.2 mg/kg/day divided q12hr initially Suitable For : Suitable For All

Send Inquiry

SEND INQUIRY CALL ME FREE